Search results - ORA - Oxford University Research Archive

1

Journal article

Antibody seroconversion in asymptomatic andsymptomatic patients infected with severe acuterespiratory syndrome coronavirus 2 (SARS-CoV-2)

Jiang, C, Wang, Y, Hu, M, et al.
2020-09-26

2

Journal article

Returning results in biobank research: Global trends and solutions.

De Clercq, E, Kaye, J, Wolf, S, et al.
2017-03-01

3

Journal article

Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.

Degrève, B, Esnouf, R, De Clercq, E, et al.
2001-02-01

4

Journal article

Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.

Degrève, B, Esnouf, R, De Clercq, E, et al.
2000-12-01

5

Journal article

Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.

Pelemans, H, Esnouf, R, Jonckheere, H, et al.
1998-12-01

6

Journal article

Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.

Van Laethem, K, Schmit, J, Pelemans, H, et al.
2000-06-01

7

Journal article

Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.

Pelemans, H, Esnouf, R, Dunkler, A, et al.
1997-11-01

8

Journal article

Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase.

Degrève, B, Esnouf, R, De Clercq, E, et al.
1999-10-01

9

Journal article

A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.

Balzarini, J, Pelemans, H, Esnouf, R, et al.
1998-02-01

10

Journal article

Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene.

Andrei, G, Snoeck, R, De Clercq, E, et al.
2000-03-01

11

Journal article

HEPT: From an investigation of lithiation of nucleosides towards a rational design of non-nucleoside reverse transcriptase inhibitors of HIV-1

Tanaka, H, Hayakawa, H, Haraguchi, K, et al.
1999-01-01

12

Journal article

Mutational analysis of trp-229 of human immunodeficiency virus type 1 reverse transcriptase (RT) identifies this amino acid residue as a prime target for the rational design of new non-nucleoside RT inhibitors.

Pelemans, H, Esnouf, R, De Clercq, E, et al.
2000-05-01

13

Journal article

Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.

Balzarini, J, Sienaert, R, Liekens, S, et al.
2002-05-01

14

Journal article

Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.

Esteban-Gamboa, A, Balzarini, J, Esnouf, R, et al.
2000-03-01

15

Journal article

Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype.

Van Laethem, K, Witvrouw, M, Pannecouque, C, et al.
2001-03-01

16

Journal article

Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.

Auwerx, J, Esnouf, R, De Clercq, E, et al.
2004-01-01

17

Journal article

The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.

Balzarini, J, Liekens, S, Esnouf, R, et al.
2002-05-01

18

Journal article

7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.

Balzarini, J, Gamboa, A, Esnouf, R, et al.
1998-10-01

19

Journal article

Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives.

Esnouf, R, Stuart, D, De Clercq, E, et al.
1997-05-01

20

Journal article

The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.

Auwerx, J, Stevens, M, Van Rompay, A, et al.
2004-07-01

21

Journal article

A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.

Pelemans, H, Esnouf, R, Parniak, M, et al.
1998-06-01

22

Journal article

Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.

Liekens, S, Leali, D, Neyts, J, et al.
1999-07-01

23

Journal article

Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.

Balzarini, J, Degrève, B, Esteban-Gamboa, A, et al.
2000-10-01

24

Journal article

Mutations at amino acid positions 63, 189, and 396 of human immunodeficiency virus type 1 reverse transcriptase (RT) partially restore the DNA polymerase activity of a Trp229Tyr mutant RT.

Pelemans, H, Esnouf, R, Min, K, et al.
2001-08-01

25

Journal article

1,1,3-Trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazine (TTD) derivatives: a new class of nonnucleoside human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitors with anti-HIV-1 activity.

Witvrouw, M, Arranz, M, Pannecouque, C, et al.
1998-03-01

EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH